These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 18457928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A, Chen J, Liu Y, Deng S, Wu Z, Huang Y, Ping Q.
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Free amino groups on the surface of chitosan nanoparticles and its characteristics].
    Lin AH, Liu YM, Ping QN.
    Yao Xue Xue Bao; 2007 Mar; 42(3):323-8. PubMed ID: 17520835
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin.
    Chen MC, Wong HS, Lin KJ, Chen HL, Wey SP, Sonaje K, Lin YH, Chu CY, Sung HW.
    Biomaterials; 2009 Dec; 30(34):6629-37. PubMed ID: 19767097
    [Abstract] [Full Text] [Related]

  • 9. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH, Sonaje K, Lin KM, Juang JH, Mi FL, Yang HW, Sung HW.
    J Control Release; 2008 Dec 08; 132(2):141-9. PubMed ID: 18817821
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A, Tozuka Y, Takeuchi H.
    Eur J Pharm Sci; 2011 Apr 18; 42(5):445-51. PubMed ID: 21182939
    [Abstract] [Full Text] [Related]

  • 14. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
    Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J.
    Eur J Pharm Sci; 2012 Aug 30; 47(1):6-15. PubMed ID: 22561106
    [Abstract] [Full Text] [Related]

  • 15. [Study of the uptake of chitosan oligosaccharide nanoparticles by A549 cells].
    Wan LQ, Hu FQ, Yuan H.
    Yao Xue Xue Bao; 2004 Mar 30; 39(3):227-31. PubMed ID: 15171662
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyaluronic acid modified chitosan nanoparticles for effective management of glaucoma: development, characterization, and evaluation.
    Wadhwa S, Paliwal R, Paliwal SR, Vyas SP.
    J Drug Target; 2010 May 30; 18(4):292-302. PubMed ID: 19943753
    [Abstract] [Full Text] [Related]

  • 20. [Preparation and characterization of biotinylated chitosan nanoparticles].
    Yao Q, Hou SX, Zhang X, Zhao G, Gou XJ, You JZ.
    Yao Xue Xue Bao; 2007 May 30; 42(5):557-61. PubMed ID: 17703783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.